Natural Pharmacia International, Inc.

BURLINGTON, MA 01803

SBIR Award Summary

Total Number of Awards 23
Total Value of Awards $7.45MM
First Award Date 09/26/94
Most Recent Award Date 09/01/17

Key Personnel

Last Name Name Awards Contact
Raleigh James Arthur Raleigh 6
Lee David Yue-Wei Lee 6
Neumeyer John L Neumeyer 6
Liu Yanze Liu 3
LI HAIXIA LI 2
LUKAS SCOTT E LUKAS 2

23 Awards Won

Phase 2 STTR

Agency: Department of Health & Human Services
Topic: PA-13-235
Budget: 09/01/17 - 08/31/18

This application for a Fast Track STTR award represents a collaboration between Natural Pharmacia International, Inc. (NPI) and McLean Hospital to initiate steps toward commercializing a isoflavone botanical product for treating alcoholism. Excessive use of alcohol accounts for much of the public health burden related to alcohol use disorders, i...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PAR-14-088
Budget: 05/05/17 - 04/30/18

PROJECT SUMMARY The goal of this project is to develop commercial 18F PET radiopharmaceuticals for evaluating the proportion of D2 receptors in the high affinity state in human diseases, including Parkinson?s disease and restless legs syndrome. The D2high receptor is the functional form of the D2 receptor to which endogenous dopamine binds. An a...

Phase 2 STTR

Agency: Department of Health & Human Services
Topic: PA-13-235
Budget: 09/20/16 - 08/31/17

DESCRIPTION (provided by applicant): This application for a Fast Track STTR award represents a collaboration between Natural Pharmacia International, Inc. (NPI) and McLean Hospital to initiate steps toward commercializing a isoflavone botanical product for treating alcoholism. Excessive use of alcohol accounts for much of the public health burde...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-13-234
Budget: 09/01/14 - 02/28/15

DESCRIPTION (provided by applicant): The goal of this project is to develop a novel agonist radioligand for evaluating the proportion of D2 receptors in the high state. The D2high receptor is thought to be the functional form of the D2 receptor to which endogenous dopamine binds. An agonist radioligand should be more sensitive to endogenous DA l...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/01/08 - 08/31/10
PI: Yanze Liu

DESCRIPTION (provided by applicant): This application is a resubmission in response to AA-04-002 from the National Institute on Alcohol Abuse and Alcoholism to continue our STTR (Phase I and II) study on the development of NPI-031G (Puerarin), an Isoflavone-C-glycoside isolated from Puerira lobota (Kudzu), as a botanical anti-craving agent for t...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/01/07 - 08/31/08
PI: Yanze Liu

DESCRIPTION (provided by applicant): This application is a resubmission in response to AA-04-002 from the National Institute on Alcohol Abuse and Alcoholism to continue our STTR (Phase I and II) study on the development of NPI-031G (Puerarin), an Isoflavone-C-glycoside isolated from Puerira lobota (Kudzu), as a botanical anti-craving agent for t...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/30/06 - 08/31/07
PI: Yanze Liu

DESCRIPTION (provided by applicant): This application is a resubmission in response to AA-04-002 from the National Institute on Alcohol Abuse and Alcoholism to continue our STTR (Phase I and II) study on the development of NPI-031G (Puerarin), an Isoflavone-C-glycoside isolated from Puerira lobota (Kudzu), as a botanical anti-craving agent for t...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic:
Budget: 05/01/04 - 04/30/05

DESCRIPTION (provided by applicant): The patented Hypoxyprobe TM system for measuring tissue hypoxia has been licensed for use in experimental animals. In addition, an FDA IND is available for the clinical application of Hypoxyprobe ru- 1 and the marker is being used in clinics in the US, Canada and Europe. Over 500 patients have received the ma...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: RFA-AA-03-05
Budget: 09/18/03 - 08/31/05

DESCRIPTION (provided by applicant): Chronic heavy ethanol consumption has major adverse effects on the mammalian liver, namely the induction of hepatocellular damage and impairment of regeneration following injury. For a medication development project focusing on alcohol liver diseases, it is essential to understand, at the molecular level, po...

Phase 2 STTR

Agency: Department of Health & Human Services
Topic: RFA-AT-00-03
Budget: 07/01/03 - 06/30/06

DESCRIPTION (Provided by applicant): The objective of this Phase I and II fast track application is to develop a standardized milk thistle product and to assure a quality controlled and reliable source for future basic and clinical studies. Natural Pharmacia International, Inc, an established natural products laboratory, has established an excel...

Load More